Siu Sai Wan
Hong Kong
NCT Number: NCT05269303
The aim is to implement an intervention program to promote the continued use of Wearable Monitoring Devices among older adults through a peer support approach facilitating the incorporation of Wearable Monitoring Devices in daily life.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Hong Kong
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participants in the intervention group will receive a home visit by a Community Healthcare Worker in the first month, and biweekly motivational messages via Whats App in the second and third months.
Time frame: Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
It will be measured using a 4-item, 5-point Likert scale adopted from Bhattacherjee (2001) and Windasari et al. (2021). The five-point scale ranges from 1 = not at all satisfied to 5 = very certain, with higher scores representing a higher chance of continuing to use the WMD.
Time frame: Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
It will be measured by checking in our database the number of days that participants wore their device, and the average amount of time worn per day. Longer time worn represents better adherence rate
Time frame: baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Quality of life will be measured using the Hong Kong version of the EuroQol 5-dimension scale. The EQ-5D-5L is comprised of five dimensions, namely, mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. The utility score ranges from 0 to 1, with higher means better quality of life
Time frame: baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
ealth service utilization includes the number of attendances at a general practitioner's office, emergency department, hospital, and general out-patient clinic. The data will be reported by the participants and confirmed with medical and attendance certificates
Time frame: baseline pre-intervention
The recruitment rate will be calculated by dividing the number of participants who are recruited and randomized, by the number of eligible participants.
Time frame: 6-month (T3) time points
The attrition rate refers to the number of participants who withdraw from the study or who are lost to follow up.
Time frame: 6-month (T3) time points
the incidence of reports of adverse events will be recorded by a staff member assigned to each of the community centres and a nurse
Time frame: 6-month (T3) time points
Incidence of reports of technical difficulties will be recorded by a staff member assigned to each of the community centres and a nurse
Time frame: baseline pre-intervention, 6-month (T3) time points
The participants will be required to complete a questionnaire that measures their attitude towards using the WMD; the perceived usefulness, perceived ease of use, and self-efficacy of using the device; and their level of anxiety about using the device. The questionnaire was drawn up by Chen and Chan (2014). This 10-point Likert scale ranges from 1 (strongly disagree) to 10 (strongly agree), with higher marks indicating a better outcome, with the exception of the item on anxiety levels, where higher marks represent a higher level of anxiety in using the WMD.
The Hong Kong Polytechnic University
Other
Optimizing the Health-related Functions of a Wearable Monitoring Device in the Daily Life of Community-dwelling Older Adults: A Randomized Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06994702
Device Ineffective
Angers, France
View Trial DetailsNCT01948375
Device Ineffective
Beijing, Beijing Municipality, China
View Trial Details